Clinical Evidence of Intravitreal Triamcinolone Acetonide in the Management of Age-Related Macular Degeneration

E-ISSN： 1873-5592|12|2|149-172

ISSN： 1389-4501

Source： Current Drug Targets, Vol.12, Iss.2, 2011-02, pp. : 149-172

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Intravitreal aflibercept injection for neovascular (wet) age-related macular degeneration

By Ohr Matthew Kaiser Peter K

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 4, 2012-03 ,pp. : 585-591

Informa Healthcare

Access to resources Recommend Favorite

The Burden of Age-Related Macular Degeneration

By Schmier Jordana K. Jones Mechelle L. Halpern Michael T.

PharmacoEconomics, Vol. 24, Iss. 4, 2006-01 ,pp. : 319-334

Adis International

Access to resources Recommend Favorite

VEGF-A polymorphisms predict short-term functional response to intravitreal ranibizumab in exudative age-related macular degeneration

By Lazzeri Stefano Figus Michele Orlandi Paola Fioravanti Anna Di Desidero Teresa Agosta Elisa Sartini Maria Sole Posarelli Chiara Nardi Marco Danesi Romano Bocci Guido

Pharmacogenomics, Vol. 14, Iss. 6, 2013-04 ,pp. : 623-630

Future Medicine

Access to resources Recommend Favorite

Systemic thromboembolic adverse events in patients treated with intravitreal anti-VEGF drugs for neovascular age-related macular degeneration: an overview

By Semeraro Francesco Morescalchi Francesco Duse Sarah Gambicorti Elena Romano Mario R Costagliola Ciro

Expert Opinion on Drug Safety, Vol. 13, Iss. 6, 2014-06 ,pp. : 785-802

Informa Healthcare

Access to resources Recommend Favorite

Pegaptanib: In Exudative Age-Related Macular Degeneration

By Siddiqui M. Asif A. Keating Gillian M.

Drugs, Vol. 65, Iss. 11, 2005-01 ,pp. : 1571-1577

Adis International

Access to resources Recommend Favorite